Document is current
Any future updates will be listed below
-
Authors
Schulman-Green, Dena https://orcid.org/0000-0003-2259-3284
Cherlin, Emily
Capasso, Renee
Mougalian, Sarah S.
Wang, Shiyi
Gross, Cary P.
Bajaj, Preeti S.
Eakle, Katherine
Patel, Sharmi
Douglas, Karin
Adelson, Kerin
-
Funding
Funding for this research was provided by:
Genentech (no grant number)
- License Information
-
More Information
Article History
First Online: 8 June 2020
Compliance with Ethical Standards
:
: Dr. Schulman-Green received funds from Genentech, Inc. to help conduct this study, including manuscript preparation and travel to present research findings. Dr. Cherlin received funds from Genentech, Inc. to help conduct this study, including manuscript preparation. Dr. Mougalian declares research funding to her institution provided by Genentech and Pfizer, and consulting services to Eisai, Celgene, and Bristol Myers Squibb. Dr. Wang received funds from Genentech, Inc. to help conduct this study. Dr. Gross declares funding support from the National Comprehensive Cancer Network, Johnson and Johnson, Pfizer, and Flatiron. Drs. Bajaj, Eakle, and Patel are employed by Genentech, Inc. Dr. Adelson received funds from Genentech, Inc. to conduct this study, and has consulted for Celgene, Huron Pharmaceutials, and Roche Diagnostics. Mrs. Capasso and Mrs. Douglas have no conflicts of interest to report.
